Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoronaVac in Healthcare Professionals
NCT04456595Phase 3Completed
- Sponsor
- Instituto Butantan
- Start
- Jul 2020
- Primary completion
- Dec 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of coronavac in coronavirus disease 2019 (COVID-19) (4 arms), sponsored by Instituto Butantan. Primary endpoints: Incidence of symptomatic SARS-CoV-2 infections and Frequency of adverse events. Started Jul 2020; status: completed.
02
Drugs
coronavac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04456595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04456595.